Shanghai Qinyi Investment

Founder Li Bin controls the firm and its related entities. He previously served as Executive Director of Yestar Healthcare, a leading medical distribution company in Asia, and maintains a close business partnership with Yestar's Chairman and CEO, James Hartono. Investment decisions appear to be made by Li Bin, likely with input from close family members and business associates involved in related acquisitions.

The firm's founder, Li Bin, is a former Executive Director of Yestar Healthcare. James Hartono, Yestar's Chairman and CEO, is cited as a long-term business partner of Li Bin. While Shanghai Qinyi is a separate legal entity focused on venture investing, the personnel overlap creates a strong strategic and informational link to the publicly traded healthcare company.

The firm operates as a generalist venture investor, deploying across the full venture lifecycle. Its mandate spans early-stage seed and start-up rounds, as well as expansion and late-stage venture opportunities. This flexible stage coverage allows the firm to back companies at their earliest formation and continue supporting them through growth phases.

There is no public record of Shanghai Qinyi making fund commitments. All available information points to a direct-investment posture, where the firm's principal deploys capital into private companies across venture stages. The entity does not appear to market itself as a limited partner in external funds.

The firm is tagged as a generalist, but its leadership history points to a core competence in healthcare services. Founder Li Bin's executive background at Yestar Healthcare, a company specializing in medical device and consumables distribution, suggests a deep understanding of China's healthcare supply chain. The firm likely scans for venture opportunities across multiple sectors with particular emphasis on healthcare-related deals.